Recruiting
Study of nivolumab treatment for patients with nasopharyngeal cancer who did not respond to or worsened after platinum chemotherapy
Registered drugNo placebo
Study of nivolumab treatment for patients with nasopharyngeal cancer who did not respond to or worsened after platinum chemotherapy
Registered drugNo placebo
- Disease:Keratinising squamous cell carcinoma of nasopharynxNasopharyngeal cancer+1
- Substances:Nivolumab
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Nivolumab
- Sponsor:Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy